Supernus Pharmaceuticals (SUPN) Change in Inventory (2012 - 2026)

Supernus Pharmaceuticals (SUPN) has 15 years of Change in Inventory data on file, last reported at $105000.0 in Q1 2026.

• Change in Inventory for Q1 2026 came in at $105000.0, up 102.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.3 million (up 166.52% YoY), and the FY2025 annual result was $7.5 million, up 147.46% from the prior year.
• Change in Inventory slipped to $105000.0 in Q1 2026 per SUPN's latest filing, from $4.2 million in the prior quarter.
• Over five years, Change in Inventory peaked at $12.9 million in Q3 2025 and troughed at -$6.9 million in Q3 2023.
• A 5-year average of $208764.7 and a median of -$2.0 million in 2024 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2022 and 2024: Change in Inventory soared 489.86% in 2022, then tumbled 251.42% in 2024.
• A 5-year view of Change in Inventory shows it stood at $11.6 million in 2022, then sank by 143.52% to -$5.0 million in 2023, then soared by 36.61% to -$3.2 million in 2024, then jumped by 231.16% to $4.2 million in 2025, then plunged by 97.49% to $105000.0 in 2026.
• Business Quant data shows SUPN's Change in Inventory at $105000.0 in Q1 2026, $4.2 million in Q4 2025, and $12.9 million in Q3 2025.